The ultimate goal, Diaz says, is to bring that cost down even further and to get this kind of testing covered by insurance companies so that it can be adopted on a much wider scale. At the time of his treatment, Lukas Wartman was able to have his cancer sequenced only because his university had a slew of sequencing machines that his colleagues could use free of charge.
